In contrast, knockdown of SIRPα in ATO-treated APL cells significantly rescued the expression of β-catenin, inhibited the increase of Foxo3a and alleviated the cell apoptosis induced by ATO. The gene discussed is FOXO3; the disease is acute promyelocytic leukemia.